AmebaGone, Inc. is a Madison-based company that is revolutionizing the fight against bacterial infections by harnessing the natural predatory behavior of Dicty amoebae. Their innovative technology aims to provide a safer alternative to antibiotics and combat antimicrobial resistance, offering a promising solution to chronic intractable infections.
With a team of experts specializing in amoebic biocontrol and strong partnerships across scientific, agricultural, and medical fields, AmebaGone is at the forefront of developing disruptive technology that challenges the conventional use of chemical antibiotics. Their groundbreaking approach has garnered recognition, including awards, grants, and patents, making them a leading global firm in the development of Dicty-derived products as antimicrobial agents.
Generated from the website